Leadis Technology To Hold Conference Call To Review Status Of Dissolution

SUNNYVALE, CA (PRWEB) November 30, 2012

Leadis Technology, Inc. (PINKSHEETS: LDIS) today announced that it plans to hold a conference call for stockholders of the company on Thursday, December 6, 2012 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to review the status of its liquidation. Stockholders may access the conference call using the following information:

Conference Call Details

Date: December 6, 2012

Time: 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time

Dial in: 1-888-205-5513 (US toll free)

Access code: 581742

About Leadis Technology, Inc.

On October 23, 2009, Leadis Technologys stockholders approved the Plan of Dissolution of the company, which provides for the complete liquidation for the company under Delaware law. An initial liquidating distribution was made to stockholders of the company on December 14, 2009 in the amount of $ 0.95 per share of common stock. The company currently expects to make at least one additional liquidating distribution prior to winding up its affairs under Delaware law, however, the specific timing and amount of any future liquidating distribution(s) is not yet known.

Cautionary Statement About Forward Looking Statements

This press release contains information about Leadis Technology’s future expectations, potential liquidating distributions, liquidation obligations, and plans that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the company’s current expectations with respect to future events and are based on its current assumptions and information currently available. Please refer to the risk factors detailed in the company’s proxy statement filed with the Securities and Exchange Commission on October 2, 2009. These forward-looking statements are neither promises nor guarantees, and the company disclaims any obligation to update the forward-looking statements.

Leave a Reply